nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—ALB—coronary artery disease	0.112	1	CbGaD
Sulfamethoxazole—CYP2C8—Fenofibrate—coronary artery disease	0.0309	0.0555	CbGbCtD
Sulfamethoxazole—CYP2C8—Gemfibrozil—coronary artery disease	0.0247	0.0444	CbGbCtD
Sulfamethoxazole—ALB—Pitavastatin—coronary artery disease	0.0242	0.0436	CbGbCtD
Sulfamethoxazole—ALB—Valsartan—coronary artery disease	0.0236	0.0424	CbGbCtD
Sulfamethoxazole—PTGS1—Acetylsalicylic acid—coronary artery disease	0.0233	0.0419	CbGbCtD
Sulfamethoxazole—CYP2C9—Fenofibrate—coronary artery disease	0.0215	0.0387	CbGbCtD
Sulfamethoxazole—CYP2C8—Clopidogrel—coronary artery disease	0.0214	0.0385	CbGbCtD
Sulfamethoxazole—CYP2C8—Pitavastatin—coronary artery disease	0.0187	0.0337	CbGbCtD
Sulfamethoxazole—ALB—Rosuvastatin—coronary artery disease	0.0178	0.0321	CbGbCtD
Sulfamethoxazole—ALB—Acetylsalicylic acid—coronary artery disease	0.0174	0.0313	CbGbCtD
Sulfamethoxazole—CYP2C9—Gemfibrozil—coronary artery disease	0.0172	0.031	CbGbCtD
Sulfamethoxazole—ALB—Captopril—coronary artery disease	0.0172	0.0309	CbGbCtD
Sulfamethoxazole—CYP2C9—Clopidogrel—coronary artery disease	0.0149	0.0269	CbGbCtD
Sulfamethoxazole—CYP3A4—Ticagrelor—coronary artery disease	0.0141	0.0253	CbGbCtD
Sulfamethoxazole—ALB—Furosemide—coronary artery disease	0.0138	0.0248	CbGbCtD
Sulfamethoxazole—ALB—Losartan—coronary artery disease	0.0135	0.0243	CbGbCtD
Sulfamethoxazole—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0134	0.0242	CbGbCtD
Sulfamethoxazole—CYP2C9—Pitavastatin—coronary artery disease	0.013	0.0235	CbGbCtD
Sulfamethoxazole—CYP2C8—Simvastatin—coronary artery disease	0.0128	0.0231	CbGbCtD
Sulfamethoxazole—CYP2C9—Valsartan—coronary artery disease	0.0127	0.0228	CbGbCtD
Sulfamethoxazole—CYP2C8—Pravastatin—coronary artery disease	0.0125	0.0226	CbGbCtD
Sulfamethoxazole—CYP2C8—Lovastatin—coronary artery disease	0.0125	0.0226	CbGbCtD
Sulfamethoxazole—CYP3A4—Fenofibrate—coronary artery disease	0.0125	0.0225	CbGbCtD
Sulfamethoxazole—CYP2C8—Atorvastatin—coronary artery disease	0.0114	0.0206	CbGbCtD
Sulfamethoxazole—CYP2C8—Losartan—coronary artery disease	0.0105	0.0188	CbGbCtD
Sulfamethoxazole—CYP3A4—Gemfibrozil—coronary artery disease	0.01	0.018	CbGbCtD
Sulfamethoxazole—CYP2C9—Rosuvastatin—coronary artery disease	0.00962	0.0173	CbGbCtD
Sulfamethoxazole—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00938	0.0169	CbGbCtD
Sulfamethoxazole—CYP2C9—Simvastatin—coronary artery disease	0.00894	0.0161	CbGbCtD
Sulfamethoxazole—CYP2C9—Lovastatin—coronary artery disease	0.00875	0.0157	CbGbCtD
Sulfamethoxazole—CYP2C9—Pravastatin—coronary artery disease	0.00875	0.0157	CbGbCtD
Sulfamethoxazole—CYP3A4—Clopidogrel—coronary artery disease	0.00868	0.0156	CbGbCtD
Sulfamethoxazole—CYP3A4—Eplerenone—coronary artery disease	0.00807	0.0145	CbGbCtD
Sulfamethoxazole—CYP2C9—Atorvastatin—coronary artery disease	0.00797	0.0143	CbGbCtD
Sulfamethoxazole—CYP2C9—Losartan—coronary artery disease	0.00729	0.0131	CbGbCtD
Sulfamethoxazole—CYP3A4—Enalapril—coronary artery disease	0.00719	0.0129	CbGbCtD
Sulfamethoxazole—CYP3A4—Rosuvastatin—coronary artery disease	0.00559	0.0101	CbGbCtD
Sulfamethoxazole—CYP3A4—Ezetimibe—coronary artery disease	0.00559	0.0101	CbGbCtD
Sulfamethoxazole—CYP2C9—cardial valve—coronary artery disease	0.00558	0.351	CbGeAlD
Sulfamethoxazole—CYP3A4—Simvastatin—coronary artery disease	0.0052	0.00935	CbGbCtD
Sulfamethoxazole—CYP3A4—Lovastatin—coronary artery disease	0.00509	0.00915	CbGbCtD
Sulfamethoxazole—CYP3A4—Pravastatin—coronary artery disease	0.00509	0.00915	CbGbCtD
Sulfamethoxazole—CYP3A4—Atorvastatin—coronary artery disease	0.00464	0.00834	CbGbCtD
Sulfamethoxazole—CYP3A4—Losartan—coronary artery disease	0.00424	0.00763	CbGbCtD
Sulfamethoxazole—NAT1—myocardium—coronary artery disease	0.00258	0.163	CbGeAlD
Sulfamethoxazole—NAT1—heart—coronary artery disease	0.0018	0.114	CbGeAlD
Sulfamethoxazole—Glisoxepide—KCNJ8—coronary artery disease	0.00154	0.463	CrCbGaD
Sulfamethoxazole—NAT1—blood—coronary artery disease	0.00135	0.0847	CbGeAlD
Sulfamethoxazole—Sulfisoxazole—EDNRA—coronary artery disease	0.000841	0.253	CrCbGaD
Sulfamethoxazole—PTGS1—artery—coronary artery disease	0.000764	0.0481	CbGeAlD
Sulfamethoxazole—PTGS1—endothelium—coronary artery disease	0.000645	0.0407	CbGeAlD
Sulfamethoxazole—ALB—heart—coronary artery disease	0.000494	0.0311	CbGeAlD
Sulfamethoxazole—PTGS1—myocardium—coronary artery disease	0.000403	0.0254	CbGeAlD
Sulfamethoxazole—CYP2C9—heart—coronary artery disease	0.000308	0.0194	CbGeAlD
Sulfamethoxazole—CYP2C9—cardiovascular system—coronary artery disease	0.000291	0.0183	CbGeAlD
Sulfamethoxazole—PTGS1—heart—coronary artery disease	0.000281	0.0177	CbGeAlD
Sulfamethoxazole—PTGS1—cardiovascular system—coronary artery disease	0.000266	0.0167	CbGeAlD
Sulfamethoxazole—CYP2C8—blood—coronary artery disease	0.000259	0.0163	CbGeAlD
Sulfamethoxazole—PTGS1—cardiac atrium—coronary artery disease	0.000241	0.0152	CbGeAlD
Sulfamethoxazole—CYP2C9—blood—coronary artery disease	0.00023	0.0145	CbGeAlD
Sulfamethoxazole—PTGS1—blood—coronary artery disease	0.00021	0.0132	CbGeAlD
Sulfamethoxazole—CYP3A4—blood—coronary artery disease	0.000175	0.011	CbGeAlD
Sulfamethoxazole—Sulfamethazine—ALB—coronary artery disease	0.000175	0.0528	CrCbGaD
Sulfamethoxazole—Dapsone—MPO—coronary artery disease	0.000175	0.0526	CrCbGaD
Sulfamethoxazole—Sulfamerazine—ALB—coronary artery disease	0.000171	0.0516	CrCbGaD
Sulfamethoxazole—Sulfamethizole—ALB—coronary artery disease	0.000133	0.04	CrCbGaD
Sulfamethoxazole—Sulfanilamide—CYP2C19—coronary artery disease	0.000118	0.0355	CrCbGaD
Sulfamethoxazole—Dapsone—CYP2C19—coronary artery disease	0.000105	0.0317	CrCbGaD
Sulfamethoxazole—Headache—Fenofibrate—coronary artery disease	7.93e-05	0.000398	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Captopril—coronary artery disease	7.93e-05	0.000398	CcSEcCtD
Sulfamethoxazole—Urticaria—Telmisartan—coronary artery disease	7.92e-05	0.000397	CcSEcCtD
Sulfamethoxazole—Cough—Timolol—coronary artery disease	7.91e-05	0.000397	CcSEcCtD
Sulfamethoxazole—Vomiting—Clopidogrel—coronary artery disease	7.91e-05	0.000397	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Simvastatin—coronary artery disease	7.91e-05	0.000397	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Furosemide—coronary artery disease	7.9e-05	0.000396	CcSEcCtD
Sulfamethoxazole—Myalgia—Ramipril—coronary artery disease	7.9e-05	0.000396	CcSEcCtD
Sulfamethoxazole—Arthralgia—Ramipril—coronary artery disease	7.9e-05	0.000396	CcSEcCtD
Sulfamethoxazole—Fatigue—Furosemide—coronary artery disease	7.89e-05	0.000396	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Telmisartan—coronary artery disease	7.88e-05	0.000395	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Telmisartan—coronary artery disease	7.88e-05	0.000395	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Losartan—coronary artery disease	7.87e-05	0.000395	CcSEcCtD
Sulfamethoxazole—Vomiting—Lovastatin—coronary artery disease	7.86e-05	0.000394	CcSEcCtD
Sulfamethoxazole—Dizziness—Eplerenone—coronary artery disease	7.85e-05	0.000394	CcSEcCtD
Sulfamethoxazole—Rash—Clopidogrel—coronary artery disease	7.85e-05	0.000394	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	7.84e-05	0.000393	CcSEcCtD
Sulfamethoxazole—Dermatitis—Clopidogrel—coronary artery disease	7.84e-05	0.000393	CcSEcCtD
Sulfamethoxazole—Asthenia—Valsartan—coronary artery disease	7.83e-05	0.000393	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Niacin—coronary artery disease	7.82e-05	0.000392	CcSEcCtD
Sulfamethoxazole—Asthenia—Olmesartan—coronary artery disease	7.8e-05	0.000391	CcSEcCtD
Sulfamethoxazole—Headache—Clopidogrel—coronary artery disease	7.79e-05	0.000391	CcSEcCtD
Sulfamethoxazole—Rash—Lovastatin—coronary artery disease	7.79e-05	0.000391	CcSEcCtD
Sulfamethoxazole—Dermatitis—Lovastatin—coronary artery disease	7.79e-05	0.000391	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Losartan—coronary artery disease	7.77e-05	0.00039	CcSEcCtD
Sulfamethoxazole—Headache—Lovastatin—coronary artery disease	7.74e-05	0.000388	CcSEcCtD
Sulfamethoxazole—Pruritus—Valsartan—coronary artery disease	7.72e-05	0.000387	CcSEcCtD
Sulfamethoxazole—Myalgia—Timolol—coronary artery disease	7.72e-05	0.000387	CcSEcCtD
Sulfamethoxazole—Arthralgia—Timolol—coronary artery disease	7.72e-05	0.000387	CcSEcCtD
Sulfamethoxazole—Vomiting—Ezetimibe—coronary artery disease	7.71e-05	0.000387	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Pravastatin—coronary artery disease	7.7e-05	0.000386	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Perindopril—coronary artery disease	7.7e-05	0.000386	CcSEcCtD
Sulfamethoxazole—Angioedema—Lisinopril—coronary artery disease	7.69e-05	0.000386	CcSEcCtD
Sulfamethoxazole—Pruritus—Olmesartan—coronary artery disease	7.69e-05	0.000386	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Losartan—coronary artery disease	7.68e-05	0.000385	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	7.67e-05	0.000385	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Captopril—coronary artery disease	7.66e-05	0.000384	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Captopril—coronary artery disease	7.66e-05	0.000384	CcSEcCtD
Sulfamethoxazole—Dizziness—Simvastatin—coronary artery disease	7.65e-05	0.000383	CcSEcCtD
Sulfamethoxazole—Rash—Ezetimibe—coronary artery disease	7.64e-05	0.000383	CcSEcCtD
Sulfamethoxazole—Dermatitis—Ezetimibe—coronary artery disease	7.64e-05	0.000383	CcSEcCtD
Sulfamethoxazole—Asthenia—Niacin—coronary artery disease	7.62e-05	0.000382	CcSEcCtD
Sulfamethoxazole—Fatigue—Losartan—coronary artery disease	7.61e-05	0.000382	CcSEcCtD
Sulfamethoxazole—Headache—Ezetimibe—coronary artery disease	7.59e-05	0.000381	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Ramipril—coronary artery disease	7.57e-05	0.00038	CcSEcCtD
Sulfamethoxazole—Vertigo—Lisinopril—coronary artery disease	7.56e-05	0.000379	CcSEcCtD
Sulfamethoxazole—Vomiting—Eplerenone—coronary artery disease	7.54e-05	0.000378	CcSEcCtD
Sulfamethoxazole—Leukopenia—Lisinopril—coronary artery disease	7.53e-05	0.000378	CcSEcCtD
Sulfamethoxazole—Nausea—Fenofibrate—coronary artery disease	7.52e-05	0.000377	CcSEcCtD
Sulfamethoxazole—Pruritus—Niacin—coronary artery disease	7.51e-05	0.000377	CcSEcCtD
Sulfamethoxazole—Asthenia—Pravastatin—coronary artery disease	7.5e-05	0.000376	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Furosemide—coronary artery disease	7.48e-05	0.000375	CcSEcCtD
Sulfamethoxazole—Rash—Eplerenone—coronary artery disease	7.48e-05	0.000375	CcSEcCtD
Sulfamethoxazole—Urticaria—Perindopril—coronary artery disease	7.48e-05	0.000375	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Trandolapril—coronary artery disease	7.48e-05	0.000375	CcSEcCtD
Sulfamethoxazole—Dermatitis—Eplerenone—coronary artery disease	7.47e-05	0.000375	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Valsartan—coronary artery disease	7.47e-05	0.000375	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Enalapril—coronary artery disease	7.45e-05	0.000374	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Perindopril—coronary artery disease	7.44e-05	0.000373	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Perindopril—coronary artery disease	7.44e-05	0.000373	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Olmesartan—coronary artery disease	7.43e-05	0.000373	CcSEcCtD
Sulfamethoxazole—Headache—Eplerenone—coronary artery disease	7.43e-05	0.000373	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Ramipril—coronary artery disease	7.42e-05	0.000372	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Ramipril—coronary artery disease	7.41e-05	0.000372	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Timolol—coronary artery disease	7.4e-05	0.000371	CcSEcCtD
Sulfamethoxazole—Pruritus—Pravastatin—coronary artery disease	7.39e-05	0.000371	CcSEcCtD
Sulfamethoxazole—Nausea—Clopidogrel—coronary artery disease	7.39e-05	0.000371	CcSEcCtD
Sulfamethoxazole—Skin disorder—Ramipril—coronary artery disease	7.35e-05	0.000369	CcSEcCtD
Sulfamethoxazole—Vomiting—Simvastatin—coronary artery disease	7.35e-05	0.000369	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Telmisartan—coronary artery disease	7.35e-05	0.000368	CcSEcCtD
Sulfamethoxazole—Cough—Lisinopril—coronary artery disease	7.34e-05	0.000368	CcSEcCtD
Sulfamethoxazole—Nausea—Lovastatin—coronary artery disease	7.34e-05	0.000368	CcSEcCtD
Sulfamethoxazole—Rash—Simvastatin—coronary artery disease	7.29e-05	0.000366	CcSEcCtD
Sulfamethoxazole—Dermatitis—Simvastatin—coronary artery disease	7.28e-05	0.000365	CcSEcCtD
Sulfamethoxazole—Asthenia—Trandolapril—coronary artery disease	7.28e-05	0.000365	CcSEcCtD
Sulfamethoxazole—Urticaria—Furosemide—coronary artery disease	7.27e-05	0.000365	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Niacin—coronary artery disease	7.26e-05	0.000364	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Timolol—coronary artery disease	7.26e-05	0.000364	CcSEcCtD
Sulfamethoxazole—Asthenia—Enalapril—coronary artery disease	7.25e-05	0.000364	CcSEcCtD
Sulfamethoxazole—Headache—Simvastatin—coronary artery disease	7.24e-05	0.000363	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Furosemide—coronary artery disease	7.23e-05	0.000363	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Furosemide—coronary artery disease	7.23e-05	0.000363	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Losartan—coronary artery disease	7.22e-05	0.000362	CcSEcCtD
Sulfamethoxazole—Dizziness—Valsartan—coronary artery disease	7.22e-05	0.000362	CcSEcCtD
Sulfamethoxazole—Anorexia—Ramipril—coronary artery disease	7.22e-05	0.000362	CcSEcCtD
Sulfamethoxazole—Nausea—Ezetimibe—coronary artery disease	7.2e-05	0.000361	CcSEcCtD
Sulfamethoxazole—Skin disorder—Timolol—coronary artery disease	7.19e-05	0.000361	CcSEcCtD
Sulfamethoxazole—Dizziness—Olmesartan—coronary artery disease	7.18e-05	0.00036	CcSEcCtD
Sulfamethoxazole—Pruritus—Trandolapril—coronary artery disease	7.18e-05	0.00036	CcSEcCtD
Sulfamethoxazole—Arthralgia—Lisinopril—coronary artery disease	7.16e-05	0.000359	CcSEcCtD
Sulfamethoxazole—Myalgia—Lisinopril—coronary artery disease	7.16e-05	0.000359	CcSEcCtD
Sulfamethoxazole—Asthenia—Telmisartan—coronary artery disease	7.15e-05	0.000359	CcSEcCtD
Sulfamethoxazole—Pruritus—Enalapril—coronary artery disease	7.15e-05	0.000359	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Pravastatin—coronary artery disease	7.15e-05	0.000359	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	7.11e-05	0.000357	CcSEcCtD
Sulfamethoxazole—Anorexia—Timolol—coronary artery disease	7.06e-05	0.000354	CcSEcCtD
Sulfamethoxazole—Pruritus—Telmisartan—coronary artery disease	7.05e-05	0.000354	CcSEcCtD
Sulfamethoxazole—Nausea—Eplerenone—coronary artery disease	7.05e-05	0.000354	CcSEcCtD
Sulfamethoxazole—Dizziness—Niacin—coronary artery disease	7.02e-05	0.000352	CcSEcCtD
Sulfamethoxazole—Urticaria—Losartan—coronary artery disease	7.01e-05	0.000352	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Losartan—coronary artery disease	6.98e-05	0.00035	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Losartan—coronary artery disease	6.98e-05	0.00035	CcSEcCtD
Sulfamethoxazole—Asthenia—Captopril—coronary artery disease	6.96e-05	0.000349	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Trandolapril—coronary artery disease	6.94e-05	0.000348	CcSEcCtD
Sulfamethoxazole—Vomiting—Valsartan—coronary artery disease	6.94e-05	0.000348	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Enalapril—coronary artery disease	6.92e-05	0.000347	CcSEcCtD
Sulfamethoxazole—Dizziness—Pravastatin—coronary artery disease	6.91e-05	0.000347	CcSEcCtD
Sulfamethoxazole—Vomiting—Olmesartan—coronary artery disease	6.91e-05	0.000347	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Ramipril—coronary artery disease	6.9e-05	0.000346	CcSEcCtD
Sulfamethoxazole—Rash—Valsartan—coronary artery disease	6.88e-05	0.000345	CcSEcCtD
Sulfamethoxazole—Dermatitis—Valsartan—coronary artery disease	6.88e-05	0.000345	CcSEcCtD
Sulfamethoxazole—Nausea—Simvastatin—coronary artery disease	6.87e-05	0.000344	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Lisinopril—coronary artery disease	6.87e-05	0.000344	CcSEcCtD
Sulfamethoxazole—Pruritus—Captopril—coronary artery disease	6.86e-05	0.000344	CcSEcCtD
Sulfamethoxazole—Rash—Olmesartan—coronary artery disease	6.85e-05	0.000344	CcSEcCtD
Sulfamethoxazole—Insomnia—Ramipril—coronary artery disease	6.85e-05	0.000343	CcSEcCtD
Sulfamethoxazole—Dermatitis—Olmesartan—coronary artery disease	6.84e-05	0.000343	CcSEcCtD
Sulfamethoxazole—Headache—Valsartan—coronary artery disease	6.84e-05	0.000343	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Telmisartan—coronary artery disease	6.82e-05	0.000342	CcSEcCtD
Sulfamethoxazole—Headache—Olmesartan—coronary artery disease	6.81e-05	0.000341	CcSEcCtD
Sulfamethoxazole—Asthenia—Perindopril—coronary artery disease	6.75e-05	0.000339	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Ramipril—coronary artery disease	6.75e-05	0.000339	CcSEcCtD
Sulfamethoxazole—Vomiting—Niacin—coronary artery disease	6.75e-05	0.000339	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Timolol—coronary artery disease	6.74e-05	0.000338	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Furosemide—coronary artery disease	6.74e-05	0.000338	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Lisinopril—coronary artery disease	6.72e-05	0.000337	CcSEcCtD
Sulfamethoxazole—Dizziness—Trandolapril—coronary artery disease	6.71e-05	0.000337	CcSEcCtD
Sulfamethoxazole—Insomnia—Timolol—coronary artery disease	6.69e-05	0.000336	CcSEcCtD
Sulfamethoxazole—Rash—Niacin—coronary artery disease	6.69e-05	0.000336	CcSEcCtD
Sulfamethoxazole—Dermatitis—Niacin—coronary artery disease	6.69e-05	0.000335	CcSEcCtD
Sulfamethoxazole—Dizziness—Enalapril—coronary artery disease	6.68e-05	0.000335	CcSEcCtD
Sulfamethoxazole—Skin disorder—Lisinopril—coronary artery disease	6.67e-05	0.000335	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Ramipril—coronary artery disease	6.66e-05	0.000334	CcSEcCtD
Sulfamethoxazole—Pruritus—Perindopril—coronary artery disease	6.66e-05	0.000334	CcSEcCtD
Sulfamethoxazole—Headache—Niacin—coronary artery disease	6.65e-05	0.000334	CcSEcCtD
Sulfamethoxazole—Vomiting—Pravastatin—coronary artery disease	6.65e-05	0.000333	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Captopril—coronary artery disease	6.63e-05	0.000333	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Timolol—coronary artery disease	6.6e-05	0.000331	CcSEcCtD
Sulfamethoxazole—Dizziness—Telmisartan—coronary artery disease	6.59e-05	0.000331	CcSEcCtD
Sulfamethoxazole—Rash—Pravastatin—coronary artery disease	6.59e-05	0.000331	CcSEcCtD
Sulfamethoxazole—Dermatitis—Pravastatin—coronary artery disease	6.58e-05	0.00033	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Ramipril—coronary artery disease	6.58e-05	0.00033	CcSEcCtD
Sulfamethoxazole—Asthenia—Furosemide—coronary artery disease	6.57e-05	0.000329	CcSEcCtD
Sulfamethoxazole—Dapsone—PTGS2—coronary artery disease	6.55e-05	0.0197	CrCbGaD
Sulfamethoxazole—Headache—Pravastatin—coronary artery disease	6.55e-05	0.000328	CcSEcCtD
Sulfamethoxazole—Anorexia—Lisinopril—coronary artery disease	6.55e-05	0.000328	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Ramipril—coronary artery disease	6.54e-05	0.000328	CcSEcCtD
Sulfamethoxazole—Fatigue—Ramipril—coronary artery disease	6.53e-05	0.000327	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Timolol—coronary artery disease	6.52e-05	0.000327	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Losartan—coronary artery disease	6.51e-05	0.000326	CcSEcCtD
Sulfamethoxazole—Nausea—Valsartan—coronary artery disease	6.49e-05	0.000325	CcSEcCtD
Sulfamethoxazole—Pruritus—Furosemide—coronary artery disease	6.47e-05	0.000325	CcSEcCtD
Sulfamethoxazole—Nausea—Olmesartan—coronary artery disease	6.45e-05	0.000324	CcSEcCtD
Sulfamethoxazole—Vomiting—Trandolapril—coronary artery disease	6.45e-05	0.000324	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Perindopril—coronary artery disease	6.44e-05	0.000323	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Timolol—coronary artery disease	6.43e-05	0.000323	CcSEcCtD
Sulfamethoxazole—Vomiting—Enalapril—coronary artery disease	6.43e-05	0.000322	CcSEcCtD
Sulfamethoxazole—Dizziness—Captopril—coronary artery disease	6.41e-05	0.000322	CcSEcCtD
Sulfamethoxazole—Rash—Trandolapril—coronary artery disease	6.4e-05	0.000321	CcSEcCtD
Sulfamethoxazole—Dermatitis—Trandolapril—coronary artery disease	6.39e-05	0.000321	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Timolol—coronary artery disease	6.39e-05	0.000321	CcSEcCtD
Sulfamethoxazole—Fatigue—Timolol—coronary artery disease	6.38e-05	0.00032	CcSEcCtD
Sulfamethoxazole—Rash—Enalapril—coronary artery disease	6.37e-05	0.00032	CcSEcCtD
Sulfamethoxazole—Dermatitis—Enalapril—coronary artery disease	6.37e-05	0.000319	CcSEcCtD
Sulfamethoxazole—Headache—Trandolapril—coronary artery disease	6.36e-05	0.000319	CcSEcCtD
Sulfamethoxazole—Vomiting—Telmisartan—coronary artery disease	6.34e-05	0.000318	CcSEcCtD
Sulfamethoxazole—Asthenia—Losartan—coronary artery disease	6.34e-05	0.000318	CcSEcCtD
Sulfamethoxazole—Headache—Enalapril—coronary artery disease	6.33e-05	0.000318	CcSEcCtD
Sulfamethoxazole—Nausea—Niacin—coronary artery disease	6.31e-05	0.000316	CcSEcCtD
Sulfamethoxazole—Rash—Telmisartan—coronary artery disease	6.29e-05	0.000315	CcSEcCtD
Sulfamethoxazole—Dermatitis—Telmisartan—coronary artery disease	6.28e-05	0.000315	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Furosemide—coronary artery disease	6.26e-05	0.000314	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Lisinopril—coronary artery disease	6.26e-05	0.000314	CcSEcCtD
Sulfamethoxazole—Pruritus—Losartan—coronary artery disease	6.25e-05	0.000313	CcSEcCtD
Sulfamethoxazole—Headache—Telmisartan—coronary artery disease	6.25e-05	0.000313	CcSEcCtD
Sulfamethoxazole—Dizziness—Perindopril—coronary artery disease	6.23e-05	0.000312	CcSEcCtD
Sulfamethoxazole—Insomnia—Lisinopril—coronary artery disease	6.21e-05	0.000312	CcSEcCtD
Sulfamethoxazole—Nausea—Pravastatin—coronary artery disease	6.21e-05	0.000311	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Ramipril—coronary artery disease	6.19e-05	0.000311	CcSEcCtD
Sulfamethoxazole—Vomiting—Captopril—coronary artery disease	6.16e-05	0.000309	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Lisinopril—coronary artery disease	6.12e-05	0.000307	CcSEcCtD
Sulfamethoxazole—Rash—Captopril—coronary artery disease	6.11e-05	0.000307	CcSEcCtD
Sulfamethoxazole—Dermatitis—Captopril—coronary artery disease	6.11e-05	0.000306	CcSEcCtD
Sulfamethoxazole—Headache—Captopril—coronary artery disease	6.07e-05	0.000305	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Timolol—coronary artery disease	6.05e-05	0.000304	CcSEcCtD
Sulfamethoxazole—Dizziness—Furosemide—coronary artery disease	6.05e-05	0.000304	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Lisinopril—coronary artery disease	6.04e-05	0.000303	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Losartan—coronary artery disease	6.04e-05	0.000303	CcSEcCtD
Sulfamethoxazole—Nausea—Trandolapril—coronary artery disease	6.03e-05	0.000302	CcSEcCtD
Sulfamethoxazole—Urticaria—Ramipril—coronary artery disease	6.01e-05	0.000302	CcSEcCtD
Sulfamethoxazole—Nausea—Enalapril—coronary artery disease	6e-05	0.000301	CcSEcCtD
Sulfamethoxazole—Vomiting—Perindopril—coronary artery disease	5.99e-05	0.0003	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Ramipril—coronary artery disease	5.99e-05	0.0003	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Ramipril—coronary artery disease	5.99e-05	0.0003	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Lisinopril—coronary artery disease	5.97e-05	0.000299	CcSEcCtD
Sulfamethoxazole—Rash—Perindopril—coronary artery disease	5.94e-05	0.000298	CcSEcCtD
Sulfamethoxazole—Dermatitis—Perindopril—coronary artery disease	5.93e-05	0.000297	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.93e-05	0.000297	CcSEcCtD
Sulfamethoxazole—Nausea—Telmisartan—coronary artery disease	5.92e-05	0.000297	CcSEcCtD
Sulfamethoxazole—Fatigue—Lisinopril—coronary artery disease	5.92e-05	0.000297	CcSEcCtD
Sulfamethoxazole—Headache—Perindopril—coronary artery disease	5.9e-05	0.000296	CcSEcCtD
Sulfamethoxazole—Urticaria—Timolol—coronary artery disease	5.88e-05	0.000295	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Timolol—coronary artery disease	5.85e-05	0.000293	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Timolol—coronary artery disease	5.85e-05	0.000293	CcSEcCtD
Sulfamethoxazole—Dizziness—Losartan—coronary artery disease	5.84e-05	0.000293	CcSEcCtD
Sulfamethoxazole—Vomiting—Furosemide—coronary artery disease	5.82e-05	0.000292	CcSEcCtD
Sulfamethoxazole—Rash—Furosemide—coronary artery disease	5.77e-05	0.000289	CcSEcCtD
Sulfamethoxazole—Dermatitis—Furosemide—coronary artery disease	5.76e-05	0.000289	CcSEcCtD
Sulfamethoxazole—Nausea—Captopril—coronary artery disease	5.76e-05	0.000289	CcSEcCtD
Sulfamethoxazole—Headache—Furosemide—coronary artery disease	5.73e-05	0.000288	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Lisinopril—coronary artery disease	5.61e-05	0.000282	CcSEcCtD
Sulfamethoxazole—Vomiting—Losartan—coronary artery disease	5.61e-05	0.000282	CcSEcCtD
Sulfamethoxazole—Nausea—Perindopril—coronary artery disease	5.59e-05	0.00028	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Ramipril—coronary artery disease	5.58e-05	0.00028	CcSEcCtD
Sulfamethoxazole—Rash—Losartan—coronary artery disease	5.57e-05	0.000279	CcSEcCtD
Sulfamethoxazole—Dermatitis—Losartan—coronary artery disease	5.56e-05	0.000279	CcSEcCtD
Sulfamethoxazole—Headache—Losartan—coronary artery disease	5.53e-05	0.000277	CcSEcCtD
Sulfamethoxazole—Urticaria—Lisinopril—coronary artery disease	5.45e-05	0.000274	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Timolol—coronary artery disease	5.45e-05	0.000274	CcSEcCtD
Sulfamethoxazole—Nausea—Furosemide—coronary artery disease	5.44e-05	0.000273	CcSEcCtD
Sulfamethoxazole—Asthenia—Ramipril—coronary artery disease	5.43e-05	0.000272	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Lisinopril—coronary artery disease	5.43e-05	0.000272	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Lisinopril—coronary artery disease	5.43e-05	0.000272	CcSEcCtD
Sulfamethoxazole—Pruritus—Ramipril—coronary artery disease	5.36e-05	0.000269	CcSEcCtD
Sulfamethoxazole—Asthenia—Timolol—coronary artery disease	5.31e-05	0.000266	CcSEcCtD
Sulfamethoxazole—Nausea—Losartan—coronary artery disease	5.24e-05	0.000263	CcSEcCtD
Sulfamethoxazole—Pruritus—Timolol—coronary artery disease	5.24e-05	0.000263	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Ramipril—coronary artery disease	5.18e-05	0.00026	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Timolol—coronary artery disease	5.06e-05	0.000254	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Lisinopril—coronary artery disease	5.06e-05	0.000254	CcSEcCtD
Sulfamethoxazole—Dizziness—Ramipril—coronary artery disease	5.01e-05	0.000251	CcSEcCtD
Sulfamethoxazole—Asthenia—Lisinopril—coronary artery disease	4.93e-05	0.000247	CcSEcCtD
Sulfamethoxazole—Dizziness—Timolol—coronary artery disease	4.89e-05	0.000246	CcSEcCtD
Sulfamethoxazole—Pruritus—Lisinopril—coronary artery disease	4.86e-05	0.000244	CcSEcCtD
Sulfamethoxazole—Vomiting—Ramipril—coronary artery disease	4.81e-05	0.000241	CcSEcCtD
Sulfamethoxazole—Rash—Ramipril—coronary artery disease	4.77e-05	0.000239	CcSEcCtD
Sulfamethoxazole—Dermatitis—Ramipril—coronary artery disease	4.77e-05	0.000239	CcSEcCtD
Sulfamethoxazole—Headache—Ramipril—coronary artery disease	4.74e-05	0.000238	CcSEcCtD
Sulfamethoxazole—Vomiting—Timolol—coronary artery disease	4.71e-05	0.000236	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Lisinopril—coronary artery disease	4.7e-05	0.000236	CcSEcCtD
Sulfamethoxazole—Rash—Timolol—coronary artery disease	4.67e-05	0.000234	CcSEcCtD
Sulfamethoxazole—Dermatitis—Timolol—coronary artery disease	4.66e-05	0.000234	CcSEcCtD
Sulfamethoxazole—Headache—Timolol—coronary artery disease	4.64e-05	0.000233	CcSEcCtD
Sulfamethoxazole—Dizziness—Lisinopril—coronary artery disease	4.54e-05	0.000228	CcSEcCtD
Sulfamethoxazole—Nausea—Ramipril—coronary artery disease	4.5e-05	0.000226	CcSEcCtD
Sulfamethoxazole—Nausea—Timolol—coronary artery disease	4.4e-05	0.000221	CcSEcCtD
Sulfamethoxazole—Vomiting—Lisinopril—coronary artery disease	4.37e-05	0.000219	CcSEcCtD
Sulfamethoxazole—Rash—Lisinopril—coronary artery disease	4.33e-05	0.000217	CcSEcCtD
Sulfamethoxazole—Dermatitis—Lisinopril—coronary artery disease	4.33e-05	0.000217	CcSEcCtD
Sulfamethoxazole—Headache—Lisinopril—coronary artery disease	4.3e-05	0.000216	CcSEcCtD
Sulfamethoxazole—Nausea—Lisinopril—coronary artery disease	4.08e-05	0.000205	CcSEcCtD
Sulfamethoxazole—ALB—Metabolism—APOC3—coronary artery disease	5.66e-06	4.98e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—LDLR—coronary artery disease	5.65e-06	4.98e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	5.65e-06	4.98e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PFKFB3—coronary artery disease	5.64e-06	4.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—COX5B—coronary artery disease	5.64e-06	4.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTM2—coronary artery disease	5.64e-06	4.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—DLAT—coronary artery disease	5.64e-06	4.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLIN1—coronary artery disease	5.64e-06	4.97e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SERPINE1—coronary artery disease	5.63e-06	4.96e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOA5—coronary artery disease	5.62e-06	4.95e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—LDLR—coronary artery disease	5.62e-06	4.95e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	5.62e-06	4.95e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTT1—coronary artery disease	5.59e-06	4.92e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC9A1—coronary artery disease	5.59e-06	4.92e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—APOE—coronary artery disease	5.56e-06	4.9e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTT1—coronary artery disease	5.56e-06	4.89e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC9A1—coronary artery disease	5.56e-06	4.89e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GCLC—coronary artery disease	5.52e-06	4.87e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CETP—coronary artery disease	5.52e-06	4.87e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—P4HB—coronary artery disease	5.51e-06	4.86e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTM1—coronary artery disease	5.51e-06	4.85e-05	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—AKT1—coronary artery disease	5.5e-06	4.85e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—APOA1—coronary artery disease	5.5e-06	4.84e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CETP—coronary artery disease	5.49e-06	4.84e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GCLC—coronary artery disease	5.49e-06	4.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	5.46e-06	4.81e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SDC1—coronary artery disease	5.46e-06	4.81e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SDC1—coronary artery disease	5.43e-06	4.78e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	5.41e-06	4.77e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—LPL—coronary artery disease	5.41e-06	4.77e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NOS3—coronary artery disease	5.38e-06	4.74e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	5.35e-06	4.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SULT1E1—coronary artery disease	5.35e-06	4.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	5.29e-06	4.66e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GPX1—coronary artery disease	5.28e-06	4.65e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.26e-06	4.64e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—JAK2—coronary artery disease	5.23e-06	4.61e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PSMB5—coronary artery disease	5.16e-06	4.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PSMA6—coronary artery disease	5.16e-06	4.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.15e-06	4.54e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CD36—coronary artery disease	5.14e-06	4.53e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PSMA6—coronary artery disease	5.13e-06	4.52e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PSMB5—coronary artery disease	5.13e-06	4.52e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKR1B1—coronary artery disease	5.1e-06	4.5e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HK2—coronary artery disease	5.1e-06	4.5e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—VCAN—coronary artery disease	5.1e-06	4.5e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PPP2CA—coronary artery disease	5.07e-06	4.47e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALDOA—coronary artery disease	5.06e-06	4.46e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CTGF—coronary artery disease	5.04e-06	4.44e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CTGF—coronary artery disease	5.01e-06	4.42e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GOT2—coronary artery disease	4.99e-06	4.4e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—HMGCR—coronary artery disease	4.99e-06	4.4e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GOT2—coronary artery disease	4.97e-06	4.38e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—HMGCR—coronary artery disease	4.97e-06	4.38e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—DCN—coronary artery disease	4.91e-06	4.33e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC27A1—coronary artery disease	4.89e-06	4.31e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—MTHFR—coronary artery disease	4.87e-06	4.29e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PPARG—coronary artery disease	4.84e-06	4.27e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CPT1B—coronary artery disease	4.8e-06	4.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LCAT—coronary artery disease	4.8e-06	4.23e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	4.8e-06	4.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALDH2—coronary artery disease	4.78e-06	4.21e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—POMC—coronary artery disease	4.78e-06	4.21e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOA4—coronary artery disease	4.71e-06	4.15e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	4.66e-06	4.11e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—LIPC—coronary artery disease	4.66e-06	4.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HBA1—coronary artery disease	4.66e-06	4.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP2C19—coronary artery disease	4.66e-06	4.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	4.66e-06	4.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOC3—coronary artery disease	4.63e-06	4.08e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AGT—coronary artery disease	4.63e-06	4.08e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—LDLR—coronary artery disease	4.6e-06	4.05e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	4.6e-06	4.05e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PLCB1—coronary artery disease	4.59e-06	4.05e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PLCB1—coronary artery disease	4.57e-06	4.02e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GCLM—coronary artery disease	4.55e-06	4.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PDHA1—coronary artery disease	4.55e-06	4.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC9A1—coronary artery disease	4.55e-06	4.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTT1—coronary artery disease	4.55e-06	4.01e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—APOE—coronary artery disease	4.53e-06	3.99e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.5e-06	3.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GCLC—coronary artery disease	4.49e-06	3.96e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CETP—coronary artery disease	4.49e-06	3.96e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—APOA1—coronary artery disease	4.48e-06	3.95e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.48e-06	3.95e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ABCA1—coronary artery disease	4.45e-06	3.92e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SDC1—coronary artery disease	4.44e-06	3.92e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ABCA1—coronary artery disease	4.43e-06	3.9e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.41e-06	3.88e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.41e-06	3.88e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ALB—coronary artery disease	4.35e-06	3.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.34e-06	3.82e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GGT1—coronary artery disease	4.31e-06	3.8e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GOT1—coronary artery disease	4.31e-06	3.8e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.29e-06	3.78e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GOT1—coronary artery disease	4.29e-06	3.78e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GGT1—coronary artery disease	4.29e-06	3.78e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HADH—coronary artery disease	4.28e-06	3.77e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.28e-06	3.77e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PSMB5—coronary artery disease	4.2e-06	3.7e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PSMA6—coronary artery disease	4.2e-06	3.7e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4.19e-06	3.69e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—NOS3—coronary artery disease	4.17e-06	3.67e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CTGF—coronary artery disease	4.1e-06	3.61e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HMGCR—coronary artery disease	4.06e-06	3.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GOT2—coronary artery disease	4.06e-06	3.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPX2—coronary artery disease	4.05e-06	3.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOA2—coronary artery disease	4.05e-06	3.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.05e-06	3.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCG5—coronary artery disease	4e-06	3.53e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4e-06	3.53e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPX4—coronary artery disease	4e-06	3.53e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HK1—coronary artery disease	4e-06	3.53e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HADHA—coronary artery disease	3.96e-06	3.49e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PPARG—coronary artery disease	3.95e-06	3.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.91e-06	3.45e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—POMC—coronary artery disease	3.89e-06	3.43e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—coronary artery disease	3.88e-06	3.41e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTP1—coronary artery disease	3.87e-06	3.41e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LPA—coronary artery disease	3.87e-06	3.41e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTP1—coronary artery disease	3.85e-06	3.39e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	3.84e-06	3.38e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—HMOX1—coronary artery disease	3.82e-06	3.37e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPARGC1A—coronary artery disease	3.81e-06	3.36e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—coronary artery disease	3.81e-06	3.36e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—HMOX1—coronary artery disease	3.8e-06	3.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CAT—coronary artery disease	3.77e-06	3.32e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CAT—coronary artery disease	3.75e-06	3.3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.75e-06	3.3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PLCB1—coronary artery disease	3.74e-06	3.29e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOA5—coronary artery disease	3.71e-06	3.27e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.67e-06	3.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOB—coronary artery disease	3.66e-06	3.22e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOB—coronary artery disease	3.64e-06	3.21e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—P4HB—coronary artery disease	3.64e-06	3.2e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCA1—coronary artery disease	3.62e-06	3.19e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.57e-06	3.14e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTM1—coronary artery disease	3.56e-06	3.14e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TGFB1—coronary artery disease	3.56e-06	3.13e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ALB—coronary artery disease	3.55e-06	3.13e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTM1—coronary artery disease	3.54e-06	3.12e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GOT1—coronary artery disease	3.51e-06	3.09e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GGT1—coronary artery disease	3.51e-06	3.09e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—LPL—coronary artery disease	3.49e-06	3.08e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MAPK1—coronary artery disease	3.49e-06	3.07e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—LPL—coronary artery disease	3.47e-06	3.06e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GPX1—coronary artery disease	3.41e-06	3e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—NOS3—coronary artery disease	3.4e-06	2.99e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GPX1—coronary artery disease	3.39e-06	2.99e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—VCAN—coronary artery disease	3.36e-06	2.96e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.34e-06	2.94e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CD36—coronary artery disease	3.32e-06	2.92e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CD36—coronary artery disease	3.3e-06	2.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPP2CA—coronary artery disease	3.28e-06	2.89e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPP2CA—coronary artery disease	3.26e-06	2.87e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—DCN—coronary artery disease	3.24e-06	2.86e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.15e-06	2.78e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTP1—coronary artery disease	3.15e-06	2.78e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—MTHFR—coronary artery disease	3.15e-06	2.77e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—MTHFR—coronary artery disease	3.13e-06	2.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	3.12e-06	2.75e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HMOX1—coronary artery disease	3.11e-06	2.74e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—coronary artery disease	3.11e-06	2.74e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LIPC—coronary artery disease	3.07e-06	2.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HBA1—coronary artery disease	3.07e-06	2.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.07e-06	2.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.07e-06	2.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CAT—coronary artery disease	3.07e-06	2.7e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOC3—coronary artery disease	3.05e-06	2.69e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LDLR—coronary artery disease	3.03e-06	2.67e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CA—coronary artery disease	3.03e-06	2.67e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTT1—coronary artery disease	3e-06	2.64e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3e-06	2.64e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AGT—coronary artery disease	2.99e-06	2.63e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOB—coronary artery disease	2.98e-06	2.62e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AGT—coronary artery disease	2.97e-06	2.62e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GCLC—coronary artery disease	2.96e-06	2.61e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CETP—coronary artery disease	2.96e-06	2.61e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SDC1—coronary artery disease	2.93e-06	2.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOE—coronary artery disease	2.93e-06	2.58e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOE—coronary artery disease	2.91e-06	2.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.9e-06	2.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOA1—coronary artery disease	2.89e-06	2.55e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOA1—coronary artery disease	2.88e-06	2.54e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—LPL—coronary artery disease	2.84e-06	2.51e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GPX1—coronary artery disease	2.77e-06	2.44e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.77e-06	2.44e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.77e-06	2.44e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.77e-06	2.44e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.76e-06	2.43e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CTGF—coronary artery disease	2.7e-06	2.38e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CD36—coronary artery disease	2.7e-06	2.38e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.68e-06	2.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GOT2—coronary artery disease	2.68e-06	2.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPP2CA—coronary artery disease	2.67e-06	2.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—MTHFR—coronary artery disease	2.56e-06	2.26e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPARG—coronary artery disease	2.55e-06	2.25e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPARG—coronary artery disease	2.54e-06	2.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—POMC—coronary artery disease	2.52e-06	2.22e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—POMC—coronary artery disease	2.5e-06	2.2e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT1—coronary artery disease	2.47e-06	2.18e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.46e-06	2.17e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AGT—coronary artery disease	2.43e-06	2.14e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.39e-06	2.11e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOE—coronary artery disease	2.38e-06	2.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOA1—coronary artery disease	2.36e-06	2.08e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CA—coronary artery disease	2.34e-06	2.07e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GOT1—coronary artery disease	2.31e-06	2.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GGT1—coronary artery disease	2.31e-06	2.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALB—coronary artery disease	2.29e-06	2.02e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.26e-06	1.99e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NOS3—coronary artery disease	2.19e-06	1.93e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NOS3—coronary artery disease	2.18e-06	1.92e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.08e-06	1.83e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPARG—coronary artery disease	2.08e-06	1.83e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.06e-06	1.81e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.05e-06	1.81e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—POMC—coronary artery disease	2.05e-06	1.8e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CAT—coronary artery disease	2.02e-06	1.78e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—coronary artery disease	2.01e-06	1.77e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—coronary artery disease	1.99e-06	1.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOB—coronary artery disease	1.96e-06	1.73e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKT1—coronary artery disease	1.91e-06	1.69e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CA—coronary artery disease	1.91e-06	1.68e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.91e-06	1.68e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LPL—coronary artery disease	1.87e-06	1.65e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALB—coronary artery disease	1.87e-06	1.64e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPX1—coronary artery disease	1.83e-06	1.61e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NOS3—coronary artery disease	1.79e-06	1.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CD36—coronary artery disease	1.78e-06	1.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.76e-06	1.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.69e-06	1.49e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.63e-06	1.44e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AGT—coronary artery disease	1.6e-06	1.41e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOE—coronary artery disease	1.57e-06	1.38e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKT1—coronary artery disease	1.56e-06	1.38e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOA1—coronary artery disease	1.55e-06	1.37e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPARG—coronary artery disease	1.37e-06	1.21e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—POMC—coronary artery disease	1.35e-06	1.19e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CA—coronary artery disease	1.23e-06	1.09e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALB—coronary artery disease	1.23e-06	1.08e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CA—coronary artery disease	1.23e-06	1.08e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NOS3—coronary artery disease	1.18e-06	1.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.08e-06	9.49e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKT1—coronary artery disease	1.01e-06	8.88e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1e-06	8.85e-06	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKT1—coronary artery disease	1e-06	8.83e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKT1—coronary artery disease	8.21e-07	7.23e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CA—coronary artery disease	6.63e-07	5.84e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKT1—coronary artery disease	5.41e-07	4.77e-06	CbGpPWpGaD
